CORNEA RESEARCH FOUNDATION OF AMERICA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1988-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cornea.org/
Clinical Trials
6
Active:0
Completed:4
Trial Phases
4 Phases
Phase 2:1
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (50.0%)Phase 2
1 (16.7%)Phase 3
1 (16.7%)Phase 4
1 (16.7%)Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2019-07-12
- Lead Sponsor
- Cornea Research Foundation of America
- Registration Number
- NCT04018417
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
Phase 3
Completed
- Conditions
- Fuchs' Endothelial DystrophyBullous Keratopathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-08-14
- Last Posted Date
- 2021-02-12
- Lead Sponsor
- Cornea Research Foundation of America
- Target Recruit Count
- 120
- Registration Number
- NCT03248037
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
Phase 4
Completed
- Conditions
- Fuchs' DystrophyCorneal Edema
- Interventions
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- Cornea Research Foundation of America
- Target Recruit Count
- 167
- Registration Number
- NCT01853696
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
Not Applicable
Terminated
- Conditions
- TransplantIntraocular Pressure
- Interventions
- Drug: 30 mg anecortave acetate
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Cornea Research Foundation of America
- Target Recruit Count
- 7
- Registration Number
- NCT00884039
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
Study of Endothelial Keratoplasty Outcomes
Not Applicable
Completed
- Conditions
- Fuchs' Endothelial Corneal DystrophyBullous KeratopathyPosterior Polymorphous DystrophyIridocorneal Endothelial Syndrome
- First Posted Date
- 2008-12-01
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Cornea Research Foundation of America
- Target Recruit Count
- 2593
- Registration Number
- NCT00800111
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
- Prev
- 1
- 2
- Next
News
No news found